References
- Alabi A, Todd A, Husband A, et al. Safety profile of lamotrigine in overdose. Ther Adv Psychopharmacol. 2016;6(6):369–381.
- Alyahya B, Friesen M, Nauche B, et al. Acute lamotrigine overdose: a systematic review of published adult and pediatric cases. Clin Toxicol. 2018;56(2):81–89.
- Ghannoum M, Hoffman RS, Gosselin S, et al. Use of extracorporeal treatments in the management of poisonings. Kidney Int. 2018;94(4):682–688.
- Polepally AR, Brundage RC, Remmel RP, et al. Lamotrigine pharmacokinetics following oral and stable-labeled intravenous administration in young and elderly adult epilepsy patients: Effect of age. Epilepsia. 2018;59(9):1718–1726.
- Rambeck B, Wolf P. Lamotrigine clinical pharmacokinetics. Clin Pharmacokinet. 1993;25(6):433–443.
- Fillastre JP, Taburet AM, Fialaire A, et al. Pharmacokinetics of lamotrigine in patients with renal impairment: influence of haemodialysis. Drugs Exp Clin Res. 1993;19(1):25–32.
- Lavergne V, Ouellet G, Bouchard J, et al. Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology. Semin Dial. 2014;27(4):407–414.
- Lavergne V, Nolin TD, Hoffman RS, et al. The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: guideline methodology. Clin Toxicol (Phila). 2012;50(5):403–413.
- Becker T, Chiew AL, Chan BSH. Intermittent haemodialysis in lamotrigine poisoning. J Clin Tox. 2019;9(4):1–4.